AI Medication Error Prevention

Medication errors can occur during prescribing, dispensing, administration, or monitoring. Clinical decision-support systems may check orders for allergies, drug interactions, duplicate therapy, contraindications, or dose ranges. AHRQ’s PSNet overview describes these functions as aids to clinical decisions; it also notes that current systems do not prevent errors at every stage or necessarily reduce all adverse drug events. A warning is not itself proof that an order is unsafe. Some alerts identify a possibility that needs chart review; others may be clinically irrelevant because data are stale or a rule is overly broad. A high-priority alert should have a clear response path, while low-value notifications should be tuned to reduce interruption. Staff should be able to report misleading rules and receive feedback when changes are made. An alert may lack relevant context, such as renal function, indication, timing, or a patient’s full medication list. Frequent low-value warnings can cause alert fatigue, while missing or overridden high-value warnings can leave risk unaddressed. Clinical teams need a process for deciding which alerts are interruptive, who responds, and how overrides are documented. AI may help prioritize or detect patterns, but any such system requires evaluation in the actual workflow. Hospitals should test rules against representative cases, review alert appropriateness and override patterns, and involve pharmacists and clinicians. Measure prescribing errors and adverse outcomes where feasible, not simply the number of warnings. Combine decision support with medication reconciliation, barcode checks, clear communication, and a reporting culture. Follow the institution’s policy and professional judgment, and treat unexpected symptoms as requiring clinical assessment even when software raised no warning.